JP2025513714A5 - - Google Patents
Info
- Publication number
- JP2025513714A5 JP2025513714A5 JP2024556078A JP2024556078A JP2025513714A5 JP 2025513714 A5 JP2025513714 A5 JP 2025513714A5 JP 2024556078 A JP2024556078 A JP 2024556078A JP 2024556078 A JP2024556078 A JP 2024556078A JP 2025513714 A5 JP2025513714 A5 JP 2025513714A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- binding fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22163663 | 2022-03-22 | ||
| EP22163663.2 | 2022-03-22 | ||
| PCT/EP2023/057248 WO2023180346A1 (en) | 2022-03-22 | 2023-03-21 | Deimmunized antibodies specific for cd3 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513714A JP2025513714A (ja) | 2025-04-30 |
| JP2025513714A5 true JP2025513714A5 (cg-RX-API-DMAC7.html) | 2026-05-12 |
Family
ID=80930505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556078A Pending JP2025513714A (ja) | 2022-03-22 | 2023-03-21 | Ｃｄ３に特異的な脱免疫抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250206819A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4496812A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513714A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240158351A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118922448A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023240297A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3246381A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315591A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023180346A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025087681A1 (en) | 2023-10-26 | 2025-05-01 | Morphosys Ag | Bispecific antibodies against cd3 and cd20 |
| KR20260113057A (ko) * | 2023-11-14 | 2026-07-21 | 리제너론 파아마슈티컬스, 인크. | 조작된 중쇄 가변 도메인 및 이의 용도 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ，インコーポレイティド | 人工抗体ポリペプチド |
| AU776910B2 (en) | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
| CA2347973C (en) | 1999-07-20 | 2010-06-22 | Morphosys Ag | Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| ATE356385T1 (de) | 2002-06-10 | 2007-03-15 | Algonomics N V | Verfahren zur vorhersage der bindungsaffinität der mhc-peptid-komplexe |
| PT2560993T (pt) | 2010-04-20 | 2024-09-16 | Genmab As | Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas |
| IL299365A (en) | 2010-05-27 | 2023-02-01 | Genmab As | Monoclonal antibodies against 2HER |
| EP2640742B1 (en) | 2010-11-19 | 2018-08-15 | MorphoSys AG | A collection of antibody sequences its use |
| WO2015070061A1 (en) * | 2013-11-07 | 2015-05-14 | Memorial Sloan-Kettering Cancer Center | Anti-wt1/hla bi-specific antibody |
| IN2014CN03887A (cg-RX-API-DMAC7.html) | 2011-10-27 | 2015-10-16 | Genmab As | |
| CN106459201A (zh) * | 2014-05-28 | 2017-02-22 | 豪夫迈·罗氏有限公司 | 结合人和食蟹猴CD3ε的抗体 |
| US11472880B2 (en) * | 2017-08-14 | 2022-10-18 | Morphosys Ag | Humanized antibodies for CD3 |
| CA3121699A1 (en) | 2018-12-05 | 2020-06-11 | Morphosys Ag | Multispecific antigen-binding molecules |
-
2023
- 2023-03-21 JP JP2024556078A patent/JP2025513714A/ja active Pending
- 2023-03-21 KR KR1020247034591A patent/KR20240158351A/ko not_active Withdrawn
- 2023-03-21 CA CA3246381A patent/CA3246381A1/en active Pending
- 2023-03-21 CN CN202380029580.4A patent/CN118922448A/zh active Pending
- 2023-03-21 US US18/847,483 patent/US20250206819A1/en active Pending
- 2023-03-21 EP EP23712893.9A patent/EP4496812A1/en active Pending
- 2023-03-21 IL IL315591A patent/IL315591A/en unknown
- 2023-03-21 WO PCT/EP2023/057248 patent/WO2023180346A1/en not_active Ceased
- 2023-03-21 AU AU2023240297A patent/AU2023240297A1/en active Pending